Maybe the company is including the $80m development costs in the ‘break even’ equation……
Does anyone know how OCC plan to manufacture more Remplir? 100,000 units pa is not enough to even cover 20% of the potential 700,000 US peripheral nerve market let alone other countries.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.015(1.15%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.33 | $1.28 | $308.8K | 238.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 713 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| OCC (ASX) Chart |